TNF polymorphisms in Lebanese patients with Behcet's disease

被引：0
|
作者：
Arayssi, T. K. [1 ]
Hamdan, A. R.
Touma, Z.
Shamseddeen, W.
Uthman, I. W.
Hourani, H. B. [2 ]
Farra, C. G. [3 ,4 ]
机构：
[1] Amer Univ Beirut, Med Ctr, Dept Internal Med, Beirut, Lebanon
[2] Chron Care Ctr, Genet Lab, Hazmieh, Lebanon
[3] Amer Univ Beirut, Dept Pathol, Beirut, Lebanon
[4] Amer Univ Beirut, Dept Lab Med, Beirut, Lebanon
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2008年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S130 / S131
页数：2
相关论文
共 50 条
  • [41] Specific interleukin-1 gene polymorphisms in Turkish patients with Behcet's disease
    Coskun, M
    Bacanli, A
    Sallakci, N
    Alpsoy, E
    Yavuzer, U
    Yegin, O
    EXPERIMENTAL DERMATOLOGY, 2005, 14 (02) : 124 - 129
  • [42] Class I and class II MHC polymorphisms in Mexican patients with Behcet's disease
    Soto-Vega, E
    García-Muñoz, R
    Richaud-Patin, Y
    Zúñiga-Ramos, J
    Crispín, JC
    Díaz-Jouanen, E
    Flores-Suárez, LF
    Llorente, L
    Granados, J
    IMMUNOLOGY LETTERS, 2004, 93 (2-3) : 211 - 215
  • [43] IFNAR1 AND IFNAR2 POLYMORPHISMS IN PATIENTS WITH BEHCET'S DISEASE
    Pay, Salih
    Musabak, Ugur
    Cobankara, Veli
    Sagkan, Rahsan I.
    Simsek, Ismail
    Keskin, Fatih
    Erdem, Hakan
    Koese, Osman
    Dinc, Ayhan
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (04) : S9 - S9
  • [44] IFNAR1 and IFNAR2 polymorphisms in patients with Behcet's disease
    Pay, S.
    Musabak, U.
    Cobankara, V.
    Sagkan, R. I.
    Simsek, I.
    Keskin, F.
    Erdem, H.
    Kose, O.
    Dinc, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (02) : S110 - S111
  • [45] Interleukin-17F gene polymorphisms in Korean patients with Behcet's disease
    Kim, S.
    Choe, J.
    Park, S.
    Kim, J.
    Lee, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 379 - 379
  • [46] Programmed Death-1 gene polymorphisms in patients with Behcet's disease in Turkey
    Duman, T.
    Duzgun, N.
    Kinikli, G.
    Tutkak, H.
    TISSUE ANTIGENS, 2011, 77 (05): : 473 - 473
  • [47] The impact of smoking on clinical features of Behcet's disease patients with glutathione S-transferase polymorphisms
    Ozer, H. T. E.
    Gunesacar, R.
    Dinkci, S.
    Ozbalkan, Z.
    Yildiz, F.
    Erken, E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (03) : S14 - S17
  • [48] Switching of anti-TNF-α agents in Behcet's disease
    Furuta, S.
    Chow, Y. W.
    Chaudhry, A. N.
    Jayne, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (03) : S62 - S68
  • [49] Management of severe complications in Behcet's disease with TNF inhibitors
    Desbois, A. C.
    Vallet, H.
    Domont, F.
    Comarmond, C.
    Cacoub, P.
    Saadoun, D.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (07) : 853 - 859
  • [50] Anti-TNF Agents in Behcet's Disease Treatment
    Tatlican, Semih
    TURKISH JOURNAL OF RHEUMATOLOGY, 2009, 24 (01) : 27 - 38
12345